|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Sep―01 |
50932 Impact of the COVID-19 Pandemic on Commonly Published Conditions in High Impact Factor Dermatology Journals |
Eli Raneses, Aubrey Winn |
2 |
[GO] |
2024―Sep―01 |
48813 Single-institution retrospective review evaluating the impact of the Covid-19 pandemic on isotretinoin prescribing practices |
Dina Poplausky, Brandon Block, Annie Chang, Sach Thakker, Jade N. Young, Nicholas Gulati, Jonathan Ungar |
3 |
[GO] |
2024―Sep―01 |
52472 Deconstructing Trends in the Equity of Teledermatology Use and Outcomes Among Acne Patients on Isotretinoin During the COVID-19 Pandemic: A Single-Center Retrospective Comparative Analysis |
Courtney Smith, Courtney Smith, Diana Wang, Deeti Pithadia, Marcia Hogeling, Carol Cheng |
4 |
[GO] |
2024―Sep―01 |
50097 Direct to Patient Synchronous Teledermatology during COVID-19 Pandemic: Lessons for future Teledermatology practice |
Neil Vaishampayan, Nicole Trupiano, Rebecca Goldberg, Haihan Zhang, Michael Tang, Ahab Chopra, Sruthi Renati, Mari Paz Castanedo Tardan, Trilokraj Tejasvi |
5 |
[GO] |
2024―Sep―01 |
54229 Incidence of Melanoma during the COVID-19 Pandemic: SEER Database Analysis |
Joshua Kent, Lori E. Ullman, Celine M. Schreidah, Emily R. Gordon, Brigit A. Lapolla |
6 |
[GO] |
2024―Sep―01 |
52543 Analyzing Post COVID-19 Patient Demographics at Dermatology Free Clinic |
Jiwon Park, Atreyu Balasundaram, Tue Nguyen, Anaya Shah, Bahar Momin, John Browning |
7 |
[GO] |
2024―Sep―01 |
54777 Cardiovascular outcomes of amyloidosis in COVID-19 patients |
Chapman Wei, Judy Hess, Angela Rosenberg, Radu Grovu, Alanna Davis, Nawal Mustafa, Chaplin Wei, Ahmad Mustafa |
8 |
[GO] |
2024―Sep―01 |
53552 Flare of Sweet Syndrome After COVID-19 Vaccination |
Daniel Xie, Jeffrey Callen |
9 |
[GO] |
2024―Sep―01 |
53188 A Global Analysis of Cutaneous Lymphomatoid Reactions after COVID-19 Vaccination |
Emily R. Gordon, Bradley D. Kwinta, Celine M. Schreidah, Oluwaseyi Adeuyan, Lauren M. Fahmy, Dawn Queen, Megan H. Trager, Cynthia M. Magro, Larisa J. Geskin |
10 |
[GO] |
2024―Sep―01 |
52629 Prevalence of alopecia areata after COVID-19 vaccination: A cross-sectional survey among 54,365 vaccine recipients at the Central Vaccination Center of Thailand |
Norachak Koomchamnarn, Chinmanart Lekhavat |
11 |
[GO] |
2024―Sep―01 |
51297 Low dose oral minoxidil in COVID-19-associated telogen effluvium. A retrospective analysis of 69 patients. |
Cesar D. Villarreal-Villareal, Daniela Mares-Custodio, Estefania Boland-Rodriguez, Juan F. Molina-de la Garza, David Saceda-Corralo |
12 |
[GO] |
2024―Sep―01 |
54699 Trends in the Mohs Micrographic Surgery Fellowship Match in the Era of COVID-19: An Analysis Comparing 2017-2019 to 2020-2022 |
Micah Belzberg, Michelle Robinson, Jordan Lim, Emily Merkel |
13 |
[GO] |
2024―Jun―27 |
A Retrospective Cohort Study Investigating Cutaneous Vasculitis in the Setting of COVID-19 Notes Higher Rates of IgA Vasculitis |
Mariam B. Elghazzawy, Shams Nassir, Jagmeet S. Arora, Michelle S. Min |
14 |
[GO] |
2024―Mar―13 |
No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic® Cosmos database |
Bella R. Lee, Autumn R. Brostek, Benjamin H. Kaffenberger |
15 |
[GO] |
2024―Feb―28 |
COVID-19 Infection Increases the Development of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Analysis |
Kristen K. Curtis, Meghan M. Dillan, Timmie R. Sharma, Joseph Piktel |
16 |
[GO] |
2024―Jan―21 |
Asynchronous Direct-to-Patient Teledermatology Visits (E-visits) during COVID-19 Pandemic: Lessons for future teledermatology practice. |
Nicole Trupiano, Rebecca H. Goldberg, Madison Novice, Jianheng Mai, Haihan Zhang, Sruthi Renati, Mari Paz Castanedo-Tardan, Trilokraj Tejasvi |
17 |
[GO] |
2023―Nov―19 |
COVID-19 pandemic-related decreases in HFMD and Scabies: A retrospective study |
Ania Stolarczyk, Julie Ryan Wolf, Alice Pentland |
18 |
[GO] |
2023―Sep―28 |
Evaluating the Role of COVID-19 Vaccines in the Landscape of Medication-induced Alopecia Areata |
Michael G. Buontempo, Lina Alhanshali, Jerry Shapiro, Kristen Lo Sicco |
19 |
[GO] |
2023―Sep―25 |
44305 Impact of rurality and insurance type on delays in melanoma diagnosis during COVID-19 |
Ananya Munjal, Madeline Fitzhugh, Smrithi Mani, Madalyn Walsh, Pavane Gorrepati, Raghav Tripathi, Vincent Liu, Jennifer Powers |
20 |
[GO] |
2023―Sep―25 |
42948 COVID-19 and Hospital Acquired Pressure Injuries: A Systematic Review |
Adrienn N. Bourkas, Michele Zaman, R. Gary Sibbald |
21 |
[GO] |
2023―Sep―25 |
44181 Reactive infectious mucocutaneous eruption secondary to Covid-19 infection |
Paula Finnegan, Muriel Sadlier |
22 |
[GO] |
2023―Sep―25 |
44451 Cutaneous Reactions of COVID-19 Infection and COVID-19 Vaccines - a Review |
Amit Singal, Amar D. Desai, Shari R. Lipner |
23 |
[GO] |
2023―Sep―25 |
43672 The Risk of COVID-19 Infection in Psoriasis Patients after Receiving UV-B Phototherapy |
Sogol Stephanie Javadi, Shahin Shahsavari, Priya Vedula Engel, Jashin J. Wu |
24 |
[GO] |
2023―Sep―25 |
42936 Comparative histopathological features of cutaneous adverse reactions after COVID-19 mRNA- and viral vector-based vaccines |
Jun Hyuk Cho, Yoon Jae Kim, Sung Jin Park, Dai Hyun Kim, Soo Hong Seo, Hyo Hyun Ahn |
25 |
[GO] |
2023―Sep―25 |
44377 COVID-19 Neurologic and Psychiatric Outcomes on Adults with Psoriasis |
Rahul Raiker, Haig Pakhchanian, Mairead R. Baker, Min Deng |
26 |
[GO] |
2023―Sep―25 |
42551 Earlier Detection of Invasive Melanoma After the COVID-19 Pandemic |
Hemali Shah, Rose Parisi, Emily Everdell, Paul Feustel, Lindy Davis |
27 |
[GO] |
2023―Sep―25 |
42407 Teledermatology in Practice: Report of Multi-site Experience During the COVID-19 Pandemic |
Nessa Aghazadeh Mohandesi, Tudor Puiu, Matthew Hall, Olayemi Sokumbi, Aaron Mangold, Michael Colgan, Megha Tollefson, Julio Sartori Valinotti |
28 |
[GO] |
2023―Sep―25 |
42406 Gender Representation in Authorship of Academic Dermatology Publications During the COVID-19 Pandemic |
Mindy Szeto, Melissa Laughter, Mayra Maymone, Payal Patel, Torunn Sivesind, Colby Presley, Steven Lada, Kayd Pulsipher, Henriette de la Garza, Robert Dellavalle |
29 |
[GO] |
2023―Sep―25 |
43455 Dermatology Resident Attitudes towards Virtual Didactics during the COVID-19 Pandemic |
Marc Schlessel, Frank Wang, Mio Nakamura |
30 |
[GO] |
2023―Sep―25 |
42346 Association of perioral dermatitis and mask usage during the COVID-19 pandemic |
William J. Nahm, Arielle R. Nagler, Emily C. Milam |
31 |
[GO] |
2023―Sep―25 |
42197 The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study |
Nicole Trepanowski, Cassandra A. Hathaway, Michael S. Chang, Jennifer L. Hay, Ravi Samatham, Susan M. Swetter, Shelley S. Tworoger, Peter A. Kanetsky, Sancy A. Leachman, Rebecca I. Hartman |
32 |
[GO] |
2023―Sep―25 |
40758 Internet Searches for “Maskne” During the COVID-19 Pandemic: A Call to Action |
Sarah Shareef, Rafey Rehman, Steven Daveluy, Darius Mehregan |
33 |
[GO] |
2023―Sep―25 |
43129 A series of 69 COVID-related dermatosis with biopsy, immunohistochemistry with antiSpike 3 and in situ hybridization and PCR: a critical reappraisal of COVID-19 skin involvement. |
Mar Llamas-Velasco, Javier Fraga, Ana Rodríguez-Villa Lario, Alba Catalá, Yosmar Carolina Pérez-González, Beatriz Butrón- Briz, Cristina Galván, Ricardo Ruiz-Villaverde, Javier Sánchez-Pérez, Thomas Wiesner, Dieter Metze |
34 |
[GO] |
2023―Sep―25 |
42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP) |
Edwin Korouri, Hannah Peterson, Fernando Valenzuela, Ricardo Romiti, Johannes Didaskalu, Alexander Egeberg, Hazel H. Oon, Danielle Yee, Kevin Artiga, Rosario Aguero, Kathryn Lee, Margaret Y. Huang, Julia- Tatjana Maul, April W. Armstrong |
35 |
[GO] |
2023―Sep―25 |
44156 Vitiligo and Lichen Planus Following COVID-19 Vaccination/Infection: A Possible Type 1 Interferon Response? |
Maxwell Green, Aileen Feschuk, Nadia Kashetsky, Howard Maibach |
36 |
[GO] |
2023―Sep―25 |
44385 COVID-19’s Neurologic and Psychiatric Effects on Adults with Eczema |
Haig Pakhchanian, Rahul Raiker, Edward Hochman, Colin Wikholm, Min Deng |
37 |
[GO] |
2023―Sep―25 |
40548 Recurrent Giant Cellulitis-like Sweet Syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine |
Penelope Hirt, Lily Park, Francisco Kerdel |
38 |
[GO] |
2023―Sep―25 |
42337 Closing Clinical Gaps in Atopic Dermatitis Management Through the Pandemic Era: The Role of Continuing Medical Education Uncovered |
Pan Chen, Tina Lowes, Anna Bartus, Caitriona Forde |
39 |
[GO] |
2023―Sep―25 |
44321 Impact of the COVID19 pandemic on Non-Melanoma Skin Cancer in Puerto Rico |
Diana V. Rodriguez-Rivera, Claudia Perez-Draper, Fabiola Pabon- Gonzalez, Idalis Cardona-Ortiz, Sheila Valentin-Nogueras, Luz Figueroa-Guzman |
40 |
[GO] |
2023―Sep―05 |
Onychomycosis not associated with poor COVID-19 clinical outcomes in a retrospective cohort study at an academic institution, NY, NY |
Kaya L. Curtis, Rhiannon C. Miller, Amar D. Desai, Shari R. Lipner |
41 |
[GO] |
2023―Sep―04 |
Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective |
Uriel Kim, Richard Hoehn, Gary K. Schwartz, Jennifer Cullen, Jeremy S. Bordeaux, Ankit Mangla, Bryan T. Carroll |
42 |
[GO] |
2023―Aug―23 |
The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study |
David D. Xiong, Jeremy Bordeaux |
43 |
[GO] |
2023―Aug―09 |
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry |
Eden Lake |
44 |
[GO] |
2023―Jun―28 |
Gaining Perspective on mRNA COVID-19 Vaccination Risk |
Warren R. Heymann |
45 |
[GO] |
2023―May―15 |
Risk of Autoimmune Skin and Connective Tissue Disorders After mRNA-based COVID-19 Vaccination |
Hyun Jeong Ju, Ju Yeong Lee, Ju Hee Han, Ji Hae Lee, Jung Min Bae, Solam Lee |
46 |
[GO] |
2023―Apr―28 |
The impact of the American Academy of Dermatology/International League of Dermatological Societies COVID-19 registry during the pandemic: 2500 cases across 72 countries |
Alexis G. Strahan, Janet E. Lubov, Sonya Prasad, Lindy P. Fox, Devon E. McMahon, Rhea Singh, Misha Rosenbach, Seemal R. Desai, Henry W. Lim, Bruce H. Thiers, George J. Hruza, Lars E. French, Esther E. Freeman |
47 |
[GO] |
2023―Apr―23 |
The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports |
Adrienne B. Shannon, Giorgos C. Karakousis |
48 |
[GO] |
2023―Apr―23 |
Response to Trepanowski et al.’s “Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study” |
Claire Drumm, Ciara Griffin, Susan Van Baarsel, Claire Quigley, Stephen Madden, Jarushka Naidoo, Karen Eustace |
49 |
[GO] |
2023―Mar―30 |
Association of Herpes zoster with COVID-19 vaccination: A Systematic Review and Meta-Analysis |
I-Ling Chen, Hsien-Yi Chiu |
50 |
[GO] |
2023―Mar―09 |
Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States |
Daniel Y. Kim, Sara Behbahani, Rebecca I. Hartman |
51 |
[GO] |
2023―Mar―03 |
Trends in Medicare Part B procedural services performed by dermatology trainees during the Covid-19 pandemic |
Christian Gronbeck, Donyell Williams, Eric Beltrami, Hao Feng |
52 |
[GO] |
2023―Feb―10 |
Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.” |
Rachel Tallman, Zachary Zinn, Michael S. Kolodney |
53 |
[GO] |
2023―Feb―04 |
Personal Connections and Preference Signaling: A Cross-Sectional Analysis of the Dermatology Residency Match during COVID-19 |
Yen Luu, Whitney Gao, Joseph Han, Angela Mihalic, Travis Vandergriff |
54 |
[GO] |
2022―Nov―26 |
Comment on "Psoriasis and COVID-19: A bidirectional Mendelian randomization study" |
Xiaoyu Gu, Xiang Chen, Minxue Shen |
55 |
[GO] |
2022―Nov―25 |
Response to comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study” |
Christos V. Chalitsios, Kostas K. Tsilidis, Ioanna Tzoulaki |
56 |
[GO] |
2022―Nov―12 |
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) Analysis of CTCL Outcomes During the COVID-19 Pandemic: A Retrospective Cohort Study |
Larisa J. Geskin, Bradley D. Kwinta, Tiffany J. Garcia-Saleem, Oleg E. Akilov, Paula Enz, Emmanuella Guenova, Pablo L. Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino, Sima Rozati, Connor J. Stonesifer, Austin Burns, William S. Stringer, Eloy Tarin, Julia J. Scarisbrick |
57 |
[GO] |
2022―Oct―14 |
Psoriasis and COVID-19: A bidirectional Mendelian randomization study |
Christos V. Chalitsios, Kostas K. Tsilidis, Ioanna Tzoulaki |
58 |
[GO] |
2022―Sep―25 |
Correction to "The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe" |
|
59 |
[GO] |
2022―Sep―20 |
The risk of COVID-19 in patients with psoriasis - a retrospective cohort study |
Jashin J. Wu, Jeffrey Liu, Akshitha Thatiparthi, Amylee Martin, Alexander Egeberg |
60 |
[GO] |
2022―Sep―12 |
35185 Impact of telehealth on duration of tetracycline prescription during COVID-19 |
Ananya Munjal, Raghav Tripathi, Patrick Kinn, Kelly Percival, Dilek Ince, Jennifer Powers |
61 |
[GO] |
2022―Sep―12 |
33168 Visual vulnerability: Daily burden and psycosocial impact of acne and video calling during COVID-19 |
Jerry Tan, Anna L. Chien, Krysten Lisella Arekapudi |
62 |
[GO] |
2022―Sep―12 |
34255 Disparity exists between urban versus rural reach of teledermatology following COVID-19 |
Alison Romisher, Alexa Cohen, Elizabeth Jones |
63 |
[GO] |
2022―Sep―12 |
34926 Dermatology education for medical students in the era of COVID-19 |
Monika F. Keiser, Quoc-Bao D. Nguyen, Kelly C. Nelson |
64 |
[GO] |
2022―Sep―12 |
32479 Level of evidence of COVID-19 articles in dermatology literature |
Mehdi Farshchian, Muhammad Osto, Jane M. Grant-Kels |
65 |
[GO] |
2022―Sep―12 |
35393 Changes in the geographic distribution of dermatology matching during the COVID-19 Cycle: A proxy for the value of away rotations |
Joseph Younis, Bryan T. Carroll |
66 |
[GO] |
2022―Sep―12 |
34296 Introduction of BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases |
Tom Hillary, An Van Laethem, Francisca Castelijns |
67 |
[GO] |
2022―Sep―12 |
32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
Brian D. Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva |
68 |
[GO] |
2022―Sep―12 |
34223 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: A multicenter retrospective cohort study |
Yuliya Lytvyn, Jorge R. Georgakopoulos, Asfandyar Mufti |
69 |
[GO] |
2022―Sep―12 |
34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab |
Hendrik Schulze-Koops, Atul Deodhar, Reinhard E. Voll, Jan Leipe, Andrew Blauvelt, Craig Leonardi, Effie Pournara, Ivette Alarcon, Weibin Bao, Vivek Trivedi, Philip J. Mease |
70 |
[GO] |
2022―Sep―12 |
35132 Investigating the progression of melanoma and squamous cell carcinomas before and after the COVID-19 lockdown |
Laura Russell, Eric Du, Kara Signorelli |
71 |
[GO] |
2022―Sep―12 |
31047 Erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine |
Gabriela Pabón-Cartagena, Natalia M. Pelet del Toro, Marian Russo |
72 |
[GO] |
2022―Sep―12 |
32433 Effect of COVID-19 on head and neck NMSC at OU Dermatology |
Justin M. McLawhorn, Lindsey Collins |
73 |
[GO] |
2022―Sep―12 |
33778 The impact and implications of COVID-19 on using scalp cooling therapy for prevention of chemotherapy-induced alopecia |
Taylor Novice, Madison Novice, Katerina Svigos, Molly Powers, Kristen Lo Sicco |
74 |
[GO] |
2022―Sep―12 |
35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis |
Mairead Baker, Haig Pakhchanian, Rahul Raiker, Min Deng |
75 |
[GO] |
2022―Sep―12 |
33642 Personal protective equipment modification by health care workers during the COVID-19 pandemic |
Nicole Trepanowski, Rachel Meltzer |
76 |
[GO] |
2022―Sep―12 |
32688 Evaluation of demographics for patients on immunomodulatory therapy during the COVID-19 pandemic |
Ruby S. Gibson, Monica Rosales Santillan, Martina L. Porter |
77 |
[GO] |
2022―Sep―12 |
32689 Comparison of pediatric dermatology diagnoses between virtual and in-person visits during the COVID-19 pandemic |
Grace Y. Duan, Adena E. Rosenblatt |
78 |
[GO] |
2022―Sep―12 |
32301 A cross sectional study on hand manifestations during COVID-19 pandemic |
Karthik Sunki |
79 |
[GO] |
2022―Sep―12 |
33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic |
Diana S. Kim, Alexa B. Kimball, Martina L. Porter |
80 |
[GO] |
2022―Sep―12 |
34398 Risk factors for the development of acne in health care workers during the COVID-19 pandemic |
Advika Dani, Amarachi Eseonu, Kristin Bibee |
81 |
[GO] |
2022―Sep―12 |
33340 Patient and provider experience with synchronous teledermatology during the COVID-19 pandemic |
Saniya Shaikh, Eric Armbrecht, Vruta Kansara |
82 |
[GO] |
2022―Sep―12 |
34543 Isotretinoin counseling amid the COVID-19 pandemic |
Ayezel Munoz, Renat Ahatov, Emily Williams |
83 |
[GO] |
2022―Sep―12 |
33214 Determining photoprotective effectiveness of face mask during COVID-19 pandemic |
Sung Jin Park, Jun Hyuk Cho, Min Seok Ham |
84 |
[GO] |
2022―Sep―12 |
33331 Dermatology residency home match incidence during the COVID-19 pandemic |
Rewan M. Abdelwahab, Luis A. Antezana, Katherine Z. Xie |
85 |
[GO] |
2022―Sep―12 |
34291 Impact of COVID-19 pandemic on dermatology patient pharmacy preferences |
Ailia Ali, Uros Rakita, Rima Ghamravi |
86 |
[GO] |
2022―Sep―12 |
33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
Miguel Angel Duarte Ferrera |
87 |
[GO] |
2022―Sep―12 |
34304 Persistence and adherence to ixekizumab treatment in patients with moderate-to-severe psoriasis before and during COVID-19 pandemic: Results from the Canadian Patient Support Program |
Wayne Gulliver, Melinda Gooderham, Catherine Reed |
88 |
[GO] |
2022―Sep―12 |
33624 Long-term cutaneous manifestations in COVID-19 patients: A systematic review |
Abhinav Grover, Franchesca Choi, Sheng Pei-Wang |
89 |
[GO] |
2022―Sep―12 |
32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis |
Betty Nguyen, Antonella Tosti |
90 |
[GO] |
2022―Sep―12 |
35283 Mucocutaneous lichen planus following Moderna COVID-19 vaccination |
Elnara Muradova, Erica Negrini, Adrienne Berke |
91 |
[GO] |
2022―Sep―12 |
35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients |
Haig Pakhchanian, Rahul Raiker, Melanie Wolf |
92 |
[GO] |
2022―Sep―12 |
35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients |
Mairead Baker, Kristen Russomanno, Rahul Raiker |
93 |
[GO] |
2022―Sep―12 |
32390 Duration and recurrence of pityriasis rosea-like reactions following COVID-19 vaccination: A registry based study of 27 cases |
Devon McMahon, Sonya Prasad, George Hruza |
94 |
[GO] |
2022―Sep―12 |
33925 Global survey shows strong impact of pandemic on skincare routines and skin health |
Nada Baalbaki |
95 |
[GO] |
2022―Sep―12 |
35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry |
Charles Lynde, Kim Papp, Jennifer Beecker, Lorne Albrecht, Isabelle Delorme, Ignacio Dei-Cas, Antonio Vieira, Lenka Rihakova, Melinda Gooderham |
96 |
[GO] |
2022―Sep―06 |
The American Academy of Dermatology & International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 Registry to Emerging Infections |
Esther E. Freeman, Cristina Galvan Casas, Sonya Prasad, Claire Fuller, Klint Peebles, Misha Rosenbach, Lindy Fox, Devon E. McMahon, Alexis Strahan, Janet Lubov, Geoffrey Chen, Cuong V. Nguyen, Allen McMillen, Henry W. Lim, Alexander J. Stratigos, Mark D. Kaufmann, George J. Hruza, Lars French |
97 |
[GO] |
2022―Jul―09 |
Disease flare in patients with dermatomyositis following COVID-19 vaccination |
Catherina X. Pan, Nathaniel Goldman, Daniel Y. Kim, Rachael Rowley, Morgan Schaefer, Avery H. LaChance, Vinod E. Nambudiri |
98 |
[GO] |
2022―Jul―01 |
Reply to “Diagnosis of Stress-Associated Dermatological Conditions in New York City Safety Net Hospitals During the Pandemic” |
James T. Pathoulas, Sonia J. Olson, Aneela Idnani, Ronda S. Farah, Maria K. Hordinsky, Alik Widge |
99 |
[GO] |
2022―Jun―30 |
Diagnosis of Stress-Associated Dermatological Conditions in New York City Safety Net Hospitals During the Pandemic |
Kristy R. Tefft, Sarah Balboul, Bijan Safai, Abigail Cline, Shoshana Marmon |
100 |
[GO] |
2022―Jun―25 |
COVID-19 Booster Exemption for Severe Dyshidrotic Eczema |
Kathryn Bentivegna, Marti J. Rothe, Jane M. Grant Kels |
101 |
[GO] |
2022―Jun―20 |
Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study |
Nicole Trepanowski, Michael S. Chang, Guohai Zhou, Maham Ahmad, Elizabeth G. Berry, Katherine Bui, William H. Butler, Emily Y. Chu, Clara Curiel-Lewandrowski, Laura E. Dellalana, Darrel L. Ellis, S. Caleb Freeman, Pavane L. Gorrepati, Douglas Grossman, Samvel Gyurdzhyan, Peter A. Kanetsky, Amber Loren Ong King, Avani M. Kolla, Christine G. Lian, Jennifer Y. Lin, Vincent Liu, Annie Lowenthal, Kelly N. McCoy, Ananya Munjal, Caitlyn N. Myrdal, Sara Perkins, Jennifer G. Powers, Corinne Rauck, Tristan C. Smart, Jennifer A. Stein, Suraj Venna, Madalyn E. Walsh, Jennifer Y. Wang, Sancy A. Leachman, Susan M. Swetter, Rebecca I. Hartman |
102 |
[GO] |
2022―Jun―19 |
This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 mRNA booster dose vaccination |
Jonathan Kantor |
103 |
[GO] |
2022―May―17 |
THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE |
C. Scharf, G. Brancaccio, A. Di Stefani, M.C. Fargnoli, H. Kittler, A. Kyrgidis, A. Lallas, C. Longo, J. Malvehy, E. Moscarella, K. Peris, S. Piana, S. Puig, L. Thomas, G. Argenziano |
104 |
[GO] |
2022―May―16 |
Prevalence of SARS-CoV-2 Infection in Asymptomatic Pre-operative Patients Scheduled for Dermatologic Surgery: A Single Center, Retrospective Chart Review |
Selcen S. Yuksel, Alvin W. Li, Simon S. Yoo |
105 |
[GO] |
2022―May―13 |
Pemphigus Vulgaris after COVID-19 Infection and Vaccination |
Henry Zou, Steven Daveluy |
106 |
[GO] |
2022―May―13 |
“Comparison of Patient Demographics at a Free Clinic Prior-to versus During the COVID-19 Pandemic” |
Paige Hoyer, Jenna Reisler, Sruti Rachapudi, Lindy Ross |
107 |
[GO] |
2022―May―13 |
Proposing a Standardized Assessment of COVID-19 Vaccine Cutaneous Reactions |
Rhea Singh, Rowanne Ali, Sonya Prasad, Steven T. Chen, Kimberly Blumenthal, Esther E. Freeman |
108 |
[GO] |
2022―May―10 |
Tofacitinib Therapy for Alopecia Areata is not Associated with Adverse Events during COVID-19 Infection |
Soundos Youssef, Jonathan Lavian, Eunice Y. Lee, Weijia Fan, Lindsey A. Bordone |
109 |
[GO] |
2022―May―10 |
A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma |
Saba S. Shaikh, Xi Yang, Dylan D. Fortman, Hong Wang, Diwakar Davar, Jason J. Luke, Hassane Zarour, John M. Kirkwood, Yana G. Najjar |
110 |
[GO] |
2022―Apr―28 |
An Analysis of Internal and Regional Dermatology Matches During the Second Year of the COVID-19 Pandemic: a Cross Sectional Study |
Travis S. Dowdle, Michael P. Ryan, Michelle B. Tarbox, Richard F. Wagner |
111 |
[GO] |
2022―Mar―30 |
COVID-19 vaccination in IMID patients receiving rituximab: a personalized regimen should be formulated |
Qian Yang, Qi Jiang, Man Man Niu, Guo Zhen Fan, Peng Hu |
112 |
[GO] |
2022―Mar―29 |
Reply to: COVID-19 vaccination in IMID patients receiving rituximab: a personalized regimen should be formulated |
Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chen Lu, Nicholas Theodosakis, R. Monina Klevens, Hossein Estiri, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov |
113 |
[GO] |
2022―Mar―09 |
Factors Influencing Willingness to Pay and Show Images with Teledermatology during the COVID-19 pandemic |
Choi CE. Ellie, Heng Li Wei, Tan YL. Sean, Phan HC. Phillip, Nisha Suyien Chandran |
114 |
[GO] |
2022―Mar―08 |
Telemedicine Management of Systemic Therapy with Isotretinoin of Patients with Moderate-to-Severe Acne During the COVID-19 Pandemic. a Longitudinal Prospective Feasibility Study |
D. Moreno-Ramírez, M.A. Duarte-Ferreras, T. Ojeda-Vila, I. García-Morales, M.D. Conejo-Mir, A. Fernández-Orland, A.I. Sánchez-del-Campo, N. Eiris, A.M. Carrizosa, A. Ruiz-de-Casas, J.M. de-la-Torre, J.M. Herrerías-Esteban, L. Ferrándiz |
115 |
[GO] |
2022―Feb―25 |
Predictors of COVID-19 Disease Severity Augment the Braden Scale in the Prediction of Pressure Ulcer Development among COVID-19-Positive Intensive Care Unit Patients: A Case-Control Study |
Brett D. McLarney, Claire L. Le Guen, Simo Huang, Frederick Ramsey, Rohit Soans, Sylvia Hsu |
116 |
[GO] |
2022―Feb―04 |
Association of psoriasis with risk of COVID-19: A two-sample Mendelian randomization study |
Xiaoyu Gu, Xiang Chen, Minxue Shen |
117 |
[GO] |
2022―Jan―29 |
Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments |
Ge Peng, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda, François Niyonsaba |
118 |
[GO] |
2022―Jan―25 |
An Analysis of Public Sunscreen Distribution in the United States During the COVID-19 Pandemic |
Mindy D. Szeto, Ryan E. Kokoska, Jalal Maghfour, Chandler W. Rundle, Colby L. Presley, Taylor Harp, Austin Hamp, Victoria Wegener, Jeremy Hugh, Robert P. Dellavalle |
119 |
[GO] |
2022―Jan―10 |
The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the Greater Houston Area: a retrospective chart review |
Kevin P. Lee, Misha V. Koshelev, Omar Pacha |
120 |
[GO] |
2021―Dec―23 |
This Month in JAAD Case Reports: March 2022 RIME secondary to SARS-CoV-2 |
Brett Sloan |
121 |
[GO] |
2021―Dec―18 |
Asymmetric patterns of patient access to in-person and teledermatologic healthcare during the COVID-19 pandemic |
Chirag Vasavda, Olive Tang, Shawn G. Kwatra, Byron K. Ho, Anna L. Grossberg |
122 |
[GO] |
2021―Dec―17 |
Maintaining patient involvement in dermatology education during the COVID-19 pandemic: Challenges and solutions |
Connie R. Shi, Lori R. Newman, Bina Kassamali, Susan Burgin |
123 |
[GO] |
2021―Dec―16 |
Cross-sectional Study of Dermatology Residency Home Match Incidence During the COVID-19 Pandemic |
Rewan Abdelwahab, Luis A. Antezana, Katherine Z. Xie, Muhab Abdelwahab, Megha Tollefson |
124 |
[GO] |
2021―Dec―11 |
Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium |
Carlos Gustavo Wambier, Antonella Tosti |
125 |
[GO] |
2021―Dec―11 |
Early onset effluvium secondary to COVID-19: A clinical and histological characterization |
Anna Carolina Miola, Lívia Caramaschi Florêncio, Maria Estela Bellini Ribeiro, Giovana Piteri Alcântara, Paulo Müller Ramos, Hélio Amante Miot |
126 |
[GO] |
2021―Dec―06 |
This Month in JAAD International: March 2022: Photography, skin cancer, and the limits of teledermatology in the COVID-19 pandemic |
Jonathan Kantor |
127 |
[GO] |
2021―Dec―04 |
Impact of COVID-19 Delays on Skin Cancer Worry and Mohs Surgery for Keratinocytic Carcinoma |
Emily Stamell Ruiz, Inge J. Veldhuizen, Aleisa Abdullah, Anthony Rossi, Kishwer S. Nehal, Chrysalyne Schmults, Abigail Waldman, Erica H. Lee |
128 |
[GO] |
2021―Nov―25 |
Pediatric Teledermatology: A retrospective review of 1199 encounters during the COVID-19 pandemic |
Sonia A. Havele, Ramie Fathy, Patrick McMahon, Aditi S. Murthy |
129 |
[GO] |
2021―Nov―23 |
Risk of Herpes Zoster Reactivation After mRNA COVID-19 Vaccination: A Cohort Study |
Morgan Birabaharan, David C. Kaelber, Maile Y. Karris |
130 |
[GO] |
2021―Nov―18 |
Response to McMahon et al.’s “Cutaneous reactions reported after Modrna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases” |
Konstantinos Poulas, Konstantinos Farsalinos |
131 |
[GO] |
2021―Nov―17 |
Skin Reactions to COVID-19 Vaccines: an AAD/ILDS Registry Update on reaction location and COVID vaccine type |
Esther E. Freeman, Qisi Sun, Devon E. McMahon, Rhea Singh, Ramie Fathy, Anisha Tyagi, Kimberly Blumenthal, George J. Hruza, Lars E. French, Lindy P. Fox |
132 |
[GO] |
2021―Oct―29 |
Incidence and Severity of COVID-19 in patients with autoimmune blistering skin diseases: a nation-wide study |
Pascal Joly, André Gillibert, Gérôme Bohelay, Karen Aouar, Saskia Ingen-Housz-Oro, Christophe Bedane, Clémence Lepelletier, Emmanuelle Tancrède Bohin, Manuelle Viguier, Nicolas Dupin., Sebastien Debarbieux, Denis Jullien, Gaelle Quereux, Cécile Morice, Antoine Mahe, Catherine Michel, Noemie Litrowski, Géraldine Jeudy, Marie Aleth Richard, Catherine Picard, Olivier Chosidow, Anne-Pham Ledard, Vivien Hebert, Sophie Duvert-Lehembre, Nadège Cordel, Marina Alexandre, Frédéric Caux |
133 |
[GO] |
2021―Oct―07 |
The risk of COVID-19 infection in patients with atopic dermatitis - a retrospective cohort study |
Jashin J. Wu, Amylee Martin, Jeffrey Liu, Akshitha Thatiparthi, Shaokui Ge, Alexander Egeberg, Jacob P. Thyssen |
134 |
[GO] |
2021―Sep―28 |
Comparison of constitutional and dermatologic side effects between COVID-19 and non-COVID-19 vaccines: review of a publicly available database of vaccine side effects |
Stephanie R. Cohen, David X. Gao, Jared S. Kahn, David Rosmarin |
135 |
[GO] |
2021―Sep―22 |
Impact of the COVID-19 pandemic on hospitalizations of patients with moderate to severe skin diseases: A retrospective cohort analysis from a Central European Center |
Franziska Schauer, Max Behrens, Sabine Müller, Frank Meiss, Dimitra Kiritsi |
136 |
[GO] |
2021―Sep―16 |
Biologic therapy is not associated with increased COVID-19 severity in Hidradenitis Suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry |
H.B. Naik, R. Alhusayen, J. Frew, S. Guilbault, N.K. Hills, J.R. Ingram, M.V. Kudlinski, M.A. Lowes, A.V. Marzano, M. Paul, B. Villumsen, C.A. Yannuzzi |
137 |
[GO] |
2021―Sep―10 |
This Month in JAAD International: November 2021: COVID-19 and hair loss |
Jonathan Kantor |
138 |
[GO] |
2021―Sep―10 |
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts |
Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chenyue Lu, Nicholas Theodosakis, R. Monina Klevens, Hossein Estir, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov |
139 |
[GO] |
2021―Sep―10 |
Utilizing Simulation Modeling to Minimize Patient-to-Patient Contact Time While Optimizing Clinical Operations During a Pandemic |
Shilpa Ghatnekar, Nurul M. Suhaimi, Jacqueline Griffin, David Rosmarin, Rebecca Yanovsky, Priyank Sharma, F. Clarissa Yang |
140 |
[GO] |
2021―Sep―10 |
Clinical and Pathologic Correlation of Cutaneous COVID-19 Vaccine Reactions including V-REPP: A Registry Based Study |
Devon E. McMahon, Carrie L. Kovarik, William Damsky, Misha Rosenbach, Jules B. Lipoff, Anisha Tyagi, Grace Chamberlin, Ramie Fathy, Rosalynn M. Nazarian, Seemal R. Desai, Henry W. Lim, Bruce H. Thiers, George J. Hruza, Lars E. French, Kimberly Blumenthal, Lindy P. Fox, Esther E. Freeman |
141 |
[GO] |
2021―Aug―28 |
Comment on “The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience” |
O. McFeely, A. Hollywood, M. Stanciu, M. O’Connell, L. Paul |
142 |
[GO] |
2021―Aug―23 |
Dermatology Patients on Biologics and Certain Other Systemic Therapies Should Receive a ‘Booster’ mRNA COVID-19 Vaccine Dose: A Critical Appraisal of Recent FDA and ACIP Recommendations |
Reid A. Waldman, Jane M. Grant-Kels |
143 |
[GO] |
2021―Aug―18 |
Instagram Usage and Engagement by Dermatology Residency Programs during the COVID-19 Pandemic compared with Twitter and Facebook |
Taylor Harp, Mindy D. Szeto, Colby L. Presley, Abigail L. Meckley, Ryan Geist, Jaclyn Anderson, Melissa R. Laughter, Chandler W. Rundle, Sameeha S. Husayn, Robert P. Dellavalle |
144 |
[GO] |
2021―Aug―14 |
Successful Implementation of Phototherapy Guidelines during the COVID-19 Pandemic |
Emma Dragan, Ariel Sher, Peter Xiong, Abigail Cline, Janet Moy |
145 |
[GO] |
2021―Aug―14 |
Response to a letter to the editor regarding “Utilization of Instagram by Dermatology Residency Programs in the era of COVID-19” |
Gabrielle Schwartzman, Azam Qureshi, Adam J. Friedman |
146 |
[GO] |
2021―Aug―14 |
Response to Implementation of Phototherapy Guidelines during Pandemic |
Henry W. Lim, Steve R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand |
147 |
[GO] |
2021―Aug―08 |
Internal and Geographic Dermatology Match Trends in the Age of COVID-19 |
Travis S. Dowdle, Michael P. Ryan, Richard F. Wagner |
148 |
[GO] |
2021―Aug―07 |
28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19 |
Tiffany J. Garcia-Saleem, Connor J. Stonesifer, Larisa J. Geskin |
149 |
[GO] |
2021―Aug―07 |
25587 The experience of COVID-19 and its impact on management of hidradenitis suppurativa |
Gabrielle Benesh, Tyler M. Andriano, Kayla M. Babbush, Steven R. Cohen |
150 |
[GO] |
2021―Aug―07 |
28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Nicholas Theodosakis, R. Monina Klevens, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov |
151 |
[GO] |
2021―Aug―07 |
27804 A cross-sectional study on the association between COVID-19 infection and hospitalization in patients with alopecia areata |
Niki Nourmohammadi, Fiore Casale, Katerina Yale, Alessandro Ghigi, Kai Zheng, Natasha Mesinkovska |
152 |
[GO] |
2021―Aug―07 |
26452 Impact of COVID-19 on patient willingness to seek in-person dermatologic care |
Rima I. Ghamrawi, Esther A. Balogh, Matthew L. Hrin, Quan Pham, Jacob J. Subash, William W. Huang, Steven R. Feldman |
153 |
[GO] |
2021―Aug―07 |
28561 The impact of telemedicine on the delivery of dermatologic care during the COVID-19 pandemic |
Vartan Pahalyants, William Murphy, Nicole Gunasekera, Daniela Kroshinsky |
154 |
[GO] |
2021―Aug―07 |
26726 A case of transient reactive papulotranslucent acrokeratoderma: Exploring the role of epidermal barrier dysfunction during the COVID-19 pandemic |
Victoria McCarver, Risa Ross, Richard Miller |
155 |
[GO] |
2021―Aug―07 |
26189 Patient Satisfaction with Teledermatology during the Covid-19 Pandemic |
Judy Hamad, Amy W. Fox, Maria S. Kammire, Alison N. Hollis, Saif Khairat |
156 |
[GO] |
2021―Aug―07 |
25777 Trends in telemedicine utilization and access for dermatologic concerns during the COVID-19 pandemic |
Michelle S. Lee, Lisa N. Guo, Vinod E. Nambudiri |
157 |
[GO] |
2021―Aug―07 |
28181 A retrospective review of continuation and discontinuation rates of biologic therapy during the COVID-19 pandemic in a single academic center dermatology practice |
Stephanie R. Cohen, David X. Gao, Jared S. Kahn, Anh H. Lam, Kristin Fiumara, David Rosmarin |
158 |
[GO] |
2021―Aug―07 |
27313 The effect of the COVID-19 pandemic on patients’ perceptions of teledermatology |
Sophia Ly, Caroline Porter, Steven R. Feldman |
159 |
[GO] |
2021―Aug―07 |
28620 The impact of the COVID-19 pandemic on perceived hair loss and stress in a cohort of alopecia areata patients: A cross-sectional study |
Chloe J. Walker, Kelly E. Flanagan, James T. Pathoulas, Isabel Pupo Wiss, Abby Ellison, Natasha Mesinkovska, Maryanne M. Senna |
160 |
[GO] |
2021―Aug―07 |
26780 Patient experiences with teledermatology during the COVID-19 pandemic: A survey |
Samuel Yeroushalmi, Sarah Hannah Millan, Kamaria Nelson, Andrew Sparks, Adam Friedman |
161 |
[GO] |
2021―Aug―07 |
28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts |
William Murphy, Nikolai Klebanov, Vartan Pahalyants, Nicholas Theodosakis, Kevin Patel, R. Monina Klevens, Evelyn Lilly, Yevgeniy R. Semenov |
162 |
[GO] |
2021―Aug―07 |
26033 Exacerbation and appearance of dermatosis during COVID-19 quarantine period in Bogotá, Colombia: A descriptive study of the psychological impairments |
David A. Castillo Molina, Jesus D. Fierro Lozada, Luisa F. Camacho-Lazaro, Mariana Reyes Rey, Daniela M. Molina Dorado, Maria Daniela Polania Tovar, Paula Andrea Chacon Jaramillo, Maria Juliana Sanchez Zapata, Nelson José Alvis-Zakzuk, Diana P. Cantillo |
163 |
[GO] |
2021―Aug―07 |
26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas |
Ramiro Rodriguez, Orlando Martinez-Luna, Rebecca Vasquez |
164 |
[GO] |
2021―Aug―07 |
26945 Purpuric pressure ulcers in hospitalized patients with COVID-19: A case series |
Sidharth Chand, Renajd Rrapi, Jennifer Lo, Sarah Song, Colleen Gabel, Niyati Desai, Mai Hoang, Daniela Kroshinsky |
165 |
[GO] |
2021―Aug―07 |
27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study |
Nikolai Klebanov, Vartan Pahalyants, William S. Murphy, Jordan T. Said, Nicholas Theodosakis, Stacey Duey, R. Monina Klevens, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov |
166 |
[GO] |
2021―Aug―07 |
28522 The impact of the SARS-CoV-2 pandemic on phototherapy utilization |
Aunna Pourang, Hailey Olds, Nneamaka Ezekwe, Henry W. Lim, Iltefat Hamzavi |
167 |
[GO] |
2021―Aug―07 |
26433 Interventions for skin wellbeing clinics in for health care staff during the SARS-CoV2 outbreak: A perspective from London (UK) |
Nav Paul, Monika Saha, Marie-Louise Daly, Luigi Citarella, Antonia D’Cruz, Athina Fonia, Rachel Healy, Ljubomir Novakovic, Alison Shanks, Kavitha Sundararaj |
168 |
[GO] |
2021―Aug―07 |
28575 Caring for skin during a pandemic: Acute facial skin changes following mask-wearing |
Rachel Elsanadi, Fiore Casale, Niki Nourmohammadi, Katerina Yale, Cristina Nguyen, Vardit Eckhouse, Yoav Cohen, Natasha Atanaskova Mesinkovska |
169 |
[GO] |
2021―Aug―04 |
COVID-19 vaccine safety and efficacy in patients with Immune-Mediated Inflammatory Disease: Review of available evidence |
Sarah Wack, Timothy Patton, Laura K. Ferris |
170 |
[GO] |
2021―Jul―24 |
Expanding Teledermatology Educational Opportunities after COVID-19 |
Shahzeb Hassan, Mohannad G. Safadi, Taha O. Mohammed, Jules B. Lipoff |
171 |
[GO] |
2021―Jul―21 |
Flipped classroom curriculum for dermatologic surgery during COVID-19: A prospective cohort study |
Michael Tassavor, Aatman Shah, Peter Hashim, Richard Torbeck |
172 |
[GO] |
2021―Jul―16 |
An Increase in Respiratory Protection Device Injuries Associated with the COVID-19 Pandemic |
Gerald McGwin, Madeleine McGwin, Russell L. Griffin |
173 |
[GO] |
2021―Jun―14 |
Clinical Manifestations and Patch test Results for Facial Dermatitis Associated with use of Disposable Face Masks during the COVID-19 Outbreak : A case-control study |
Seok Young Kang, Bo Young Chung, Jin Cheol Kim, Chun Wook Park, Hye One Kim |
174 |
[GO] |
2021―Jun―08 |
July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations |
Brett Sloan |
175 |
[GO] |
2021―Jun―05 |
Importance of nose wires in face masks in reply to: “Diagnostic and management considerations for “maskne” in the era of COVID-19” |
Bina Kassamali, Kylee JB. Kus, Michelle S. Min, Gabriela A. Cobos, Avery H. LaChance, Daniel R. Mazori |
176 |
[GO] |
2021―May―27 |
Delayed skin cancer diagnosis in 2020 due to the COVID-19-related restrictions: data from an institutional registry |
Aimilios Lallas, Athanassios Kyrgidis, Sofia-Magdalini Manoli, Chryssoula Papageorgiou, Konstantinos Lallas, Elena Sotiriou, Efstratios Vakirlis, Theodoros Sidiropoulos, Dimitrios Ioannides, Zoe Apalla |
177 |
[GO] |
2021―May―26 |
Mild to moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients. |
Lidia Rudnicka, Adriana Rakowska, Anna Waskiel-Burnat, Marta Kurzeja, Malgorzata Olszewska |
178 |
[GO] |
2021―May―12 |
Genetic correlation analysis does not associate male pattern baldness with COVID-19 |
Hamzeh M. Tanha, Sarah Medland, Nicholas G. Martin, Dale R. Nyholt |
179 |
[GO] |
2021―May―12 |
Differences in Virtual Care Utilization for Acne for Vulnerable Populations during the COVID-19 Pandemic: A Retrospective Review |
Michelle S. Lee, Bina Kassamali, Nidhi Shah, Avery LaChance, Vinod E. Nambudiri |
180 |
[GO] |
2021―Apr―17 |
Response to Comment on “An Evidence-Based Guide to SARS-Cov-1 2 Vaccination of Patients on Immunotherapies in Dermatology.” |
Louise M. Gresham, Barbara Marzario, Jan Dutz, Mark G. Kirchhof |
181 |
[GO] |
2021―Apr―08 |
Race, Ethnicity and Comorbidities are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID- 19 Pandemic |
Abigail Cline, Ashley Keyes Jacobs, Maira Fonseca, Julia Wu, Falguni Asrani, Bijan Safai, Sharon Glick, Beth N. McLellan, Amy J. McMichael, Shoshana Marmon |
182 |
[GO] |
2021―Apr―07 |
Cutaneous Reactions Reported after Moderna and Pfizer COVID-19 Vaccination: A Registry-Based Study of 414 Cases |
Devon E. McMahon, Erin Amerson, Misha Rosenbach, Jules B. Lipoff, Danna Moustafa, Anisha Tyagi, Seemal R. Desai, Lars E. French, Henry W. Lim, Bruce H. Thiers, George J. Hruza, Kimberly Blumenthal, Lindy P. Fox, Esther E. Freeman |
183 |
[GO] |
2021―Apr―03 |
#DermTwitter and digital mentorship in the COVID-19 era |
David X. Zheng, Kathleen M. Mulligan, Jeffrey F. Scott |
184 |
[GO] |
2021―Apr―02 |
Mucocutaneous Manifestations in Hospitalized Children with COVID-19 |
David Andina-Martinez, Montserrat Nieto-Moro, Jose Antonio Alonso-Cadenas, Juan Añon-Hidalgo, Angela Hernandez-Martin, Esther Perez-Suarez, Isabel Colmenero-Blanco, Maria Isabel Iglesias-Bouza, Julia Cano-Fernandez, Ana Mateos-Mayo, Antonio Torrelo |
185 |
[GO] |
2021―Apr―01 |
Utilization of Instagram by Dermatology Residency Programs in the era of COVID-19 |
Gabrielle Schwartzman, Azam Qureshi, Adam J. Friedman |
186 |
[GO] |
2021―Mar―27 |
May 2021: Heterogeneity in reported skin manifestations of COVID-19 and vaccines |
Jonathan Kantor |
187 |
[GO] |
2021―Mar―23 |
Cutaneous manifestations of SARS-CoV-2 - a two-center, prospective, case-controlled study |
L. Unterluggauer, I. Pospischil, C. Krall, S. Saluzzo, S. Kimeswenger, M. Karolyi, C. Wenisch, B. Lamprecht, E. Guenova, S. Winkler, C. Viczenczova, A. Bergthaler, W. Weninger, W. Hoetzenecker, G. Stary |
188 |
[GO] |
2021―Mar―20 |
The Significance of Pressure Injuries and Purpura in COVID-19 Patients Hospitalized at a Large Urban Academic Medical Center: A Retrospective Cohort Study |
Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K. Gabel, Sarah Song, Zachary Holcomb, Christopher Iriarte, Kevin Moore, Connie R. Shi, Hannah Song, Fan Di Xia, Daniel Yanes, Rajesh Gandhi, Virginia A. Triant, Daniela Kroshinsky |
189 |
[GO] |
2021―Mar―18 |
Preliminary Outcomes of 2020-2021 Dermatology Residency Application Cycle and Adverse Effects of COVID-19 |
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Jashin J. Wu |
190 |
[GO] |
2021―Mar―18 |
The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study |
Khalaf Kridin, Yochai Schonmann, Orly Weinstein, Enno Schmidt, Ralf J. Ludwig, Arnon D. Cohen |
191 |
[GO] |
2021―Mar―18 |
Comment on “An Evidence-Based Guide to SARS-Cov-2 Vaccination of Patients on Immunotherapies in Dermatology.” |
Reinhart Speeckaert, Jo Lambert, Luis Puig, Marijn Speeckaert, Hilde Lapeere, Sofie De Schepper, Nanja van Geel |
192 |
[GO] |
2021―Mar―13 |
Dermatology applicant perspectives of a virtual visiting rotation in the era of COVID-19 |
Nagasai C. Adusumilli, Jessica Kalen, Kayleigh Hausmann, Adam J. Friedman |
193 |
[GO] |
2021―Mar―05 |
A response to ‘’Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children’’ |
Ahmet Sert |
194 |
[GO] |
2021―Feb―26 |
COVID-19 impacts on dermatologic surgery patients: a single institution experience |
Melissa J. Danesh, Martina Porter, Katherine Brag, Prerna Salian, Suzanne Olbricht |
195 |
[GO] |
2021―Feb―25 |
Comment on “The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries” |
Kelsey Baab, Cory Dunnick, Robert P. Dellavalle |
196 |
[GO] |
2021―Feb―25 |
Reply To “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries’” |
Esther E. Freeman, Devon E. McMahon, Seemal R. Desai, Lindy P. Fox |
197 |
[GO] |
2021―Feb―11 |
COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study |
Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodríguez-Jiménez, Mónica Antoñanzas Basa, Rosa Feltes Ochoa, Teresa Puertolas, Eva Muñoz, José Luis Manzano, Ivan Marquez-Rodas, Juan Martín-Liberal, Ainara Soria, Pilar Lopez Criado, Almudena García Castaño, Aram Boada, Pablo Ayala de Miguel, Susana Puig, Guillermo Crespo, Pablo Luna Fra, Cristina Aguayo Zamora, Marta Feito Rodríguez, Lara Valles, Ana Drozdowskyj, Cayetana Maldonado Seral, Jesús Gardeazabal, Laura Villalobos, Rafael Rosell, Luis Antonio Fernandez-Morales, Alberto Rodrigo, Santiago Viteri, Mariano Provencio, Alfonso Berrocal |
198 |
[GO] |
2021―Feb―05 |
Seroconversion of SARS-CoV-2 infected patients on immunosuppression: a retrospective analysis |
Jeffrey S. Smith, Jordan T. Said, Scott A. Elman, Claire E.P. Smith, Joseph F. Merola |
199 |
[GO] |
2021―Jan―19 |
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients |
Angelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, Valeria Gaspari, Pamela Vezzoli, Vincenzo Maione, Cosimo Misciali, Paolo Sena, Annalisa Patrizi, Annamaria Offidani, Pietro Quaglino, Renato Arco, Marzia Caproni, Miriam Rovesti, Giorgio Bordin, Sebastiano Recalcati, Concetta Potenza, Claudio Guarneri, Gabriella Fabbrocini, Carlo Tomasini, Mariarita Sorci, Maurizio Lombardo, Paolo Gisondi, Andrea Conti, Giovanni Casazza, Ketty Peris, Piergiacomo Calzavara-Pinton, Emilio Berti |
200 |
[GO] |
2021―Jan―19 |
The Magnitude of COVID-19’s Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers |
Justin W. Marson, Brittany S. Maner, Tanner P. Harding, John Meisenheimer, James A. Solomon, Matt Leavitt, Nicole J. Levin, Robert Dellavalle, Ian Brooks, Darrell S. Rigel |
201 |
[GO] |
2021―Jan―19 |
An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology |
Louise M. Gresham, Barbara Marzario, Jan Dutz, Mark G. Kirchhof |
202 |
[GO] |
2021―Jan―11 |
Chronic Hydroxychloroquine Therapy and COVID-19 Outcomes: A Retrospective Case-Control Analysis |
Lauren K. Rangel, Payal Shah, Kristen Lo Sicco, Avrom S. Caplan, Alisa Femia |
203 |
[GO] |
2021―Jan―08 |
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments |
J.M. Gelfand, A.W. Armstrong, S. Bell, G.L. Anesi, A. Blauvelt, C. Calabrese, E.D. Dommasch, S.R. Feldman, D. Gladman, L. Kircik, M. Lebwohl, V. Lo Re, G. Martin, J.F. Merola, J.U. Scher, S. Schwartzman, J.R. Treat, A.S. Van Voorhees, C.T. Ellebrecht, J. Fenner, A. Ocon, M.N. Syed, E.J. Weinstein, G. Gondo, S. Heydon, S. Koons, C.T. Ritchlin |
204 |
[GO] |
2020―Dec―25 |
Eruptions and Related Clinical Course Among 296 Hospitalized Adults with Confirmed COVID-19 |
Sergey Rekhtman, Rachel Tannenbaum, Andrew Strunk, Morgan Birabaharan, Shari Wright, Nicole Grbic, Ashna Joseph, Stephanie K. Lin, Aaron C. Zhang, Eric C. Lee, Erika Rivera, Michael Qiu, John Chelico, Amit Garg |
205 |
[GO] |
2020―Dec―25 |
Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study |
Hamidreza Mahmoudi, Ali Salehi Farid, Ali Nili, Dorsa Dayani, Soheil Tavakolpour, Tahereh Soori, Amir Teimourpour, Ahdie Isazade, Robabeh Abedini, Kamran Balighi, Maryam Daneshpazhooh |
206 |
[GO] |
2020―Dec―25 |
The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience |
Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker, John T. Miura, Michael E. Ming, Emily Y. Chu, Giorgos C. Karakousis |
207 |
[GO] |
2020―Dec―11 |
Trends in teledermatology utilization during clinic reopening following COVID-19 closures |
Mack Y. Su, Gideon P. Smith, Shinjita Das |
208 |
[GO] |
2020―Dec―10 |
A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19 |
Abigail Cline, Abrahem Kazemi, Janet Moy, Bijan Safai, Shoshana Marmon |
209 |
[GO] |
2020―Dec―10 |
Impact of Paycheck Protection Program on dermatology practices during the COVID-19 pandemic. |
Imene Ben lagha, Bichchau Michelle Nguyen |
210 |
[GO] |
2020―Dec―05 |
Dermatological surgery during the COVID-19 pandemic: experience of a large academic center |
Michael W. Tee, Claire Stewart, Saud Aliessa, Max Polansky, Kalee Shah, Tatyana Petukhova, Anthony Rossi, Shari R. Lipner, Kira Minkis |
211 |
[GO] |
2020―Dec―03 |
Cross-sectional Survey Examining Skin Picking and Hair Pulling Disorders During The COVID-19 Pandemic |
James T. Pathoulas, Sonia J. Olson, Aneela Idnani, Ronda S. Farah, Maria K. Hordinsky, Alik Widge |
212 |
[GO] |
2020―Nov―27 |
The oral cavity cannot be forgotten in the COVID-19 era: is there a connection between dermatological and oral manifestations? |
Larissa Marques Bemquerer, José Alcides Almeida de Arruda, Marina Pereira Dias Soares, Ricardo Alves Mesquita, Tarcília Aparecida Silva |
213 |
[GO] |
2020―Nov―19 |
Retrospective Study of Trends in Dermatology Telemedicine and In-Person Visits at an Academic Center During COVID-19 |
Rhiannon C. Miller, Claire R. Stewart, Shari R. Lipner |
214 |
[GO] |
2020―Nov―19 |
A glossary of pandemic-related terms |
Benjamin B. Norton, David M. Morens, Scott A. Norton |
215 |
[GO] |
2020―Nov―12 |
Impact of the COVID-19 pandemic on inpatient dermatology consult patterns at a tertiary care hospital: A retrospective cohort study |
Meredith C. Rogers, Matthew M. Wallace, Lee Wheless, Anna K. Dewan |
216 |
[GO] |
2020―Nov―05 |
If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19 |
Qiannan Xu, Lihong Chen, Xia Li, Jie Zheng |
217 |
[GO] |
2020―Oct―30 |
Evidence Following Guidelines: Another COVID-19 Paradox |
Warren R. Heymann |
218 |
[GO] |
2020―Oct―30 |
Letter in Reply: Toward a COVID-19 Vaccine Strategy for Pemphigus Patients on Rituximab |
Reid A. Waldman, Marina Creed, Kelley Sharp, Jonas Adalsteinnson, Jaime Imitola, Timothy Durso, Jun Lu |
219 |
[GO] |
2020―Oct―28 |
Analysis of Availability of Online Dermatology Appointments During COVID-19 |
Lilly Gu, Laura Xiang, Shari Lipner |
220 |
[GO] |
2020―Oct―26 |
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis |
O. Baniandrés-Rodríguez, J. Vilar-Alejo, R. Rivera, J.M. Carrascosa, E. Daudén, E. Herrera-Acosta, A. Sahuquillo-Torralba, F.J. Gómez-García, L.M. Nieto-Benito, P. de la Cueva, J.L. López-Estebaranz, I. Belinchón, M. Ferrán, M. Alsina, L. Rodriguez, G. Carretero, C. García-Donoso, F. Ballescá, M. Llamas-Velasco, E. Herrera-Ceballos, R. Botella-Estrada, D.P. Ruiz-Genao, J. Riera-Monroig, M.A. Descalzo, I. García-Doval |
221 |
[GO] |
2020―Oct―24 |
Mucocutaneous Disease and Related Clinical Characteristics in Hospitalized Children and Adolescents with COVID-19 and MIS-C |
Sergey Rekhtman, Rachel Tannenbaum, Andrew Strunk, Morgan Birabaharan, Shari Wright, Amit Garg |
222 |
[GO] |
2020―Oct―24 |
Letter to the Editor: A response to ‘Male Balding is a Major Risk Factor for Severe COVID-19’ |
Akshitha Thatiparthi, Jeffrey Liu, Amylee Martin, Jashin J. Wu |
223 |
[GO] |
2020―Oct―24 |
Reply to letter to the editor: “A response to ‘Male Balding is a Major Risk Factor for Severe COVID-19’” |
Ahmed Yousaf, Michael Kolodney |
224 |
[GO] |
2020―Oct―23 |
COVID-19 and healthcare disparities: Innovative ways to meet the dermatologic needs of patients experiencing homelessness |
Samantha M. Guhan, Neera R. Nathan, Haya Raef, Margaret Cavanaugh-Hussey, Jennifer K. Tan |
225 |
[GO] |
2020―Oct―16 |
Hydroxychloroquine prescribing habits and impact by the COVID-19 pandemic |
Drew Kuraitis, Andrea Murina |
226 |
[GO] |
2020―Oct―14 |
Cutaneous findings in hospitalized and critically-ill patients with COVID-19: A case series of 15 patients |
Mark A. Strom, Megan H. Trager, Dmitriy Timerman, Alexandra J. Coromilas, Katy Burris, Donald V. Belsito, Ariel Eber, Sophie Greenberg, Sameera Husain, Jesse M. Lewin, Fludiona Naka, Christina C. Patrone, Aaron Coulon, Chelsea Cooper, Frederick B. Bartholomew, Melissa Beck, Margaret L. Dowd, Courtney Ensslin, Stephanie M. Gallitano, Eric Loesch, Dana M. Malajian, Laura Melnick, George W. Niedt, Laura N. Uwakwe, Ha Linh Vu, Robert R. Walther, Faramarz H. Samie, Larisa J. Geskin |
227 |
[GO] |
2020―Oct―04 |
CHILBLAIN-LIKE LESIONS AND COVID-19 INFECTION: A PROSPECTIVE OBSERVATIONAL STUDY AT SPAIN´S GROUND ZERO |
M. Feito-Rodríguez, A. Mayor-Ibarguren, Cámara Hijón, D. Montero-Vega, G. Servera-Negre, E. Ruiz-Bravo, P. Nozal, J.L. Rodríguez-Peralto, A.B. Enguita, L.Y. Bravo-Gallego, M. Granados-Fernández, C. Fernández-Alcalde, A. Fernández-Heredero, M. Alonso-Riaño, V. Jiménez-Yuste, A. Nuño-González, R. De Lucas-Laguna, E. López-Granados, P. Herranz-Pinto |
228 |
[GO] |
2020―Oct―01 |
Diagnostic and Management Considerations for ‘Maskne’ in the Era of COVID-19 |
Wan-Lin Teo |
229 |
[GO] |
2020―Oct―01 |
COVID-19 Compels Closer Scrutiny of Disparities in Dermatology |
Laurie A. Temiz, Lynn McKinley-Grant, Donald A. Glass, Valerie M. Harvey |
230 |
[GO] |
2020―Oct―01 |
Comment on “Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic” |
Andac Salman, Elif Cömert-Özer, Kübra Esen-Salman |
231 |
[GO] |
2020―Sep―30 |
The Continuing Impact of COVID-19 on Dermatology Practice: Office Workflow, Economics and Future Implications |
Graham H. Litchman, Justin W. Marson, Darrell S. Rigel |
232 |
[GO] |
2020―Sep―30 |
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients |
Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Alba Guglielmo, Annalisa Patrizi, Iria Neri |
233 |
[GO] |
2020―Sep―30 |
Response to: “Applying to dermatology residency during the COVID-19 pandemic” |
Erisa Alia, Lauren Skudalski, Jun Lu |
234 |
[GO] |
2020―Sep―30 |
Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic” |
Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu |
235 |
[GO] |
2020―Sep―17 |
A national webinar for dermatology applicants during the COVID-19 pandemic |
Caitlin M. Brumfiel, Itisha S. Jefferson, Albert G. Wu, Jennifer L. Strunck, Surya Veerabagu, Krysta Lin, Robert T. Brodell, Ilana S. Rosman |
236 |
[GO] |
2020―Sep―17 |
Occupational Dermatoses Among Frontline Healthcare Workers During the COVID-19 Pandemic: A Cross-Sectional Survey |
Nicole Trepanowski, Allison R. Larson, Rachel Evers-Meltzer |
237 |
[GO] |
2020―Sep―15 |
Patient and Physician Perspectives on Teledermatology at an Academic Dermatology Department amid the COVID-19 Pandemic |
Emmanuella Ngozi Asabor, Christopher G. Bunick, Jeffrey M. Cohen, Sara H. Perkins |
238 |
[GO] |
2020―Sep―15 |
Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil |
Joao Avancini, Denise Miyamoto, Marcelo Arnone, Tatiana Villas-Boas Gabbi, Paula Silva Ferreira, Cyro Festa Neta, Jose Antonio Sanches |
239 |
[GO] |
2020―Sep―11 |
Clinical Outcomes of CoVid-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate: A Multi-Center Research Network Study |
Ahmed Yousaf, Swapna Gayam, Steve Feldman, Zachary Zinn, Michael Kolodney |
240 |
[GO] |
2020―Sep―11 |
Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals |
Carlos Gustavo Wambier, John McCoy, Andy Goren |
241 |
[GO] |
2020―Sep―10 |
Timing of PCR and Antibody Testing in Patients with COVID-19 associated dermatologic manifestations |
Esther E. Freeman, Devon E. McMahon, George J. Hruza, Jules B. Lipoff, Lars E. French, Lindy P. Fox, Marlys S. Fassett |
242 |
[GO] |
2020―Sep―04 |
Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic” |
Brittney Schultz, David R. Pearson, Matthew Mansh |
243 |
[GO] |
2020―Sep―04 |
Authors’ Reply to the comment ‘Treatment considerations for patients with pemphigus during the COVID-19 pandemic’ |
Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F. Murrell, Julia S. Lehman |
244 |
[GO] |
2020―Sep―04 |
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 |
J.M. Gelfand, A.W. Armstrong, S. Bell, G.L. Anesi, A. Blauvelt, C. Calabrese, E.D. Dommasch, S.R. Feldman, D. Gladman, L. Kircik, M. Lebwohl, Re V. Lo, G. Martin, J.F. Merola, J.U. Scher, S. Schwartzman, J.R. Treat, A.S. Van Voorhees, C.T. Ellebrecht, J. Fenner, A. Ocon, M.N. Syed, E.J. Weinstein, J. Smith, G. Gondo, S. Heydon, S. Koons, C.T. Ritchlin |
245 |
[GO] |
2020―Aug―26 |
Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in psoriasis patients - A meta-estimate of pivotal phase 3 trials relevant to decision-making during the COVID-19 pandemic |
Maha N. Syed, Mohsin Shah, Daniel B. Shin, Marilyn T. Wan, Kevin L. Winthrop, Joel M. Gelfand |
246 |
[GO] |
2020―Aug―26 |
Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19” |
Domen Bukovac, Urška Makše |
247 |
[GO] |
2020―Aug―26 |
Reply to “Comment on androgenetic alopecia present in the majority of patients hospitalized with COVID-19” |
Carlos G. Wambier |
248 |
[GO] |
2020―Aug―20 |
Strategies for Effective Medical Student Education in Dermatology During the COVID-19 Pandemic |
Sepideh Ashrafzadeh, Sotonye E. Imadojemu, Ruth Ann Vleugels, Elizabeth A. Buzney |
249 |
[GO] |
2020―Aug―19 |
Skin is a potential host of SARS-CoV-2: a clinical, single-cell transcriptome-profiling and histological study. |
Yangbai Sun, Renpeng Zhou, Hao Zhang, Liu Rong, Wang Zhou, Yimin Liang, Qingfeng Li |
250 |
[GO] |
2020―Aug―18 |
Expansion of asynchronous teledermatology during the COVID-19 pandemic |
Mack Y. Su, Shinjita Das |
251 |
[GO] |
2020―Aug―18 |
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic |
Robert Stavert, Ahou Meydani-Korb, Dianne de Leon, Rebecca Osgood, Jessamyn Blau, Thien Luu |
252 |
[GO] |
2020―Aug―14 |
Remote Learning for Medical Student-Level Dermatology During the COVID-19 Pandemic |
Payal M. Patel, Cindy L. Tsui, Aakaash Varma, Jacob Levitt |
253 |
[GO] |
2020―Aug―08 |
COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases |
Michael Kasperkiewicz |
254 |
[GO] |
2020―Aug―08 |
All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions |
Marco Denina, Francesco Pellegrino, Francesco Morotti, Paola Coppo, Ilaria Maria Bonsignori, Silvia Garazzino, Paolo Ravanini, Maria Avolio, Rossana Cavallo, Luigi Bertolotti, Enrico Felici, Gabriela Acucella, Davide Montin, Ivana Rabbone, Francesco Licciardi |
255 |
[GO] |
2020―Aug―07 |
Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist |
Antonio Martinez-Lopez, Carlos Cuenca-Barrales, Trinidad Montero-Vilchez, Alejandro Molina-Leyva, Salvador Arias-Santiago |
256 |
[GO] |
2020―Jul―29 |
Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign |
Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, Suraj Pai, Rachita Dhurat, Andy Goren |
257 |
[GO] |
2020―Jul―29 |
Androgenetic alopecia in COVID-19: Compared to what? |
Benjamin A. Nanes |
258 |
[GO] |
2020―Jul―28 |
Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak |
Jesse Veenstra, Connor R. Buechler, Gabrielle Robinson, Stephanie Chapman, Madeline Adelman, Aaron Tisack, Peter Dimitrion, Erika Todter, Laurie Kohen, Henry W. Lim |
259 |
[GO] |
2020―Jul―28 |
Assessing The Risk of Adalimumab Use For Hidradenitis Suppurativa During The COVID-19 Pandemic |
Donovan G. Kearns, Vipawee S. Chat, Shelley Uppal, Jashin J. Wu |
260 |
[GO] |
2020―Jul―22 |
Male Balding is a Major Risk Factor for Severe COVID-19. |
Justin Lee, Ahmed Yousaf, Wei Fang, Michael Kolodney |
261 |
[GO] |
2020―Jul―22 |
Hand Hygiene During COVID-19: Recommendations from the American Contact Dermatitis Society |
Chandler W. Rundle, Colby L. Presley, Michelle Militello, Cara Barber, Douglas L. Powell, Sharon E. Jacob, Amber Reck Atwater, Kalman L. Watsky, Jiade Yu, Cory A. Dunnick |
262 |
[GO] |
2020―Jul―21 |
Google search increase in patient self-care during COVID-19 lockdown |
Tamara Searle, Firas Al-Niaimi, Faisal R. Ali |
263 |
[GO] |
2020―Jul―21 |
Approaching the dermatology residency application process during a pandemic |
Ilana S. Rosman, Courtney R. Schadt, Sara S. Samimi, Misha Rosenbach |
264 |
[GO] |
2020―Jul―16 |
Guiding Principles for Prioritization of Limited In-person Dermatology Appointments During the COVID-19 Pandemic |
Benjamin K. Stoff, Travis W. Blalock, Robert A. Swerlick, Jamie B. MacKelfresh, Leslie P. Lawley, Suephy C. Chen |
265 |
[GO] |
2020―Jul―16 |
Optimizing Education for Dermatology Residents During the COVID-19 Pandemic |
Parth Patel, Anthony K. Guzman, Beth McLellan, Rachel Blasiak |
266 |
[GO] |
2020―Jul―16 |
Risk assessment of outpatient dermatology practice in the setting of the Covid-19 pandemic |
Pedram Gerami, Walter J. Liszewski |
267 |
[GO] |
2020―Jul―16 |
Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts |
Dedee F. Murrell, Anne W. Lucky, Julio C. Salas-Alanis, David T. Woodley, Francis Palisson, Ken Natsuga, Milos Nikolic, Mae Ramirez-Quizon, Amy S. Paller, Irene Lara-Corrales, Mohammadreza Amir Barzegar, Eli Sprecher, Cristina Has, Martin Laimer, Anna L. Bruckner, Asli Bilgic, Arti Nanda, Diana Purvis, Alain Hovnanian, Slobodna Murat-Sušić, Johannes Bauer, Johannes S. Kern, Christine Bodemer, Linda K. Martin, Jemima Mellerio, Cezary Kowaleski, Susan J. Robertson, Leena Bruckner-Tuderman, Elena Pope, M Peter Marinkovich, Jean Y. Tang, John Su, Jouni Uitto, Lawrence F. Eichenfield, Joyce Teng, Mark Jean Aan Koh, Sang Eun Lee, Phuong Khuu, Heather I. Rishel, Mette Sommerlund, Karen Wiss, Chao-Kai Hsu, Tor Wo Chiu, Anna E. Martinez |
268 |
[GO] |
2020―Jul―16 |
Prevalence of cheilitis in Health care workers managing COVID-19 patients |
Mehak Singh, Atul Bothra, Manoj Pawar, Anshu Maheswari, Apoorv Tiwari, Pankaj Adhicari |
269 |
[GO] |
2020―Jul―16 |
The digital divide: how Covid-19’s telemedicine expansion could exacerbate disparities |
Mina Bakhtiar, Nada Elbuluk, Jules B. Lipoff |
270 |
[GO] |
2020―Jul―16 |
Lack of association between chilblains outbreak and SARS-CoV-2: histological and serological findings from a new immunoassay |
Vivien Hébert, Anne-Bénédicte Duval-Modeste, Pascal Joly, Véronique Lemée, Lucie Cellier, Fabienne Jouen, Benoit Veber, Laurent Drouot, Olivier Boyer |
271 |
[GO] |
2020―Jul―15 |
Caution in the time of rashes and COVID-19 |
Matthew D. Vesely, Sara H. Perkins |
272 |
[GO] |
2020―Jul―15 |
Treatment discontinuation and rate of disease transmission in psoriasis patients on biologic therapy during the COVID-19 pandemic - A Canadian Multicenter Retrospective Study |
Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Jensen Yeung |
273 |
[GO] |
2020―Jul―08 |
Applying to dermatology residency during the COVID-19 pandemic |
Donovan G. Kearns, Vipawee S. Chat, Shelley Uppal, Jashin J. Wu |
274 |
[GO] |
2020―Jul―08 |
Approach to VIPs during the COVID-19 pandemic and beyond |
Ha Eun Kong, Benjamin K. Stoff |
275 |
[GO] |
2020―Jul―08 |
Conducting Inpatient Dermatology Consultations and Maintaining Resident Education in the COVID-19 Telemedicine Era |
Margaret I. Hammond, Timmie R. Sharma, Kevin D. Cooper, Mara G. Beveridge |
276 |
[GO] |
2020―Jul―03 |
New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus |
Gilles Battesti, Jihane El Khalifa, Nour Abdelhedi, Valentine Ferre, Fabrice Bouscarat, Catherine Picard-Dahan, Florence Brunet-Possenti, Gilles Collin, Justine Lavaud, Patrick Le Bozec, Marion Rousselot, Amélie Tournier, Coralie Lheure, Anne Couvelard, Salima Hacein-Bey-Abina, Amine.M. Abina, Charlotte Charpentier, Sabine Mignot, Pascale Nicaise, Diane Descamps, Lydia Deschamps, Vincent Descamps |
277 |
[GO] |
2020―Jul―02 |
Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy |
Zachary E. Holcomb, Monica Rosales Santillan, Peyton C. Morss-Walton, Prerna Salian, Min Ji Her, Nicole M. Giannotti, Alexa B. Kimball, Martina L. Porter |
278 |
[GO] |
2020―Jul―02 |
The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic |
Maha N. Syed, Daniel B. Shin, Marilyn T. Wan, Kevin L. Winthrop, Joel M. Gelfand |
279 |
[GO] |
2020―Jul―02 |
Cling film for mobile phone to prevent cross-infection during COVID-19 pandemic |
Mitanjali Sethy, Vamshi Krishna, Chakravarthi R. Srinivas |
280 |
[GO] |
2020―Jul―02 |
The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries |
Esther E. Freeman, Devon E. McMahon, Jules B. Lipoff, Misha Rosenbach, Carrie Kovarik, Seemal R. Desai, Joanna Harp, Junko Takeshita, Lars E. French, Henry W. Lim, Bruce H. Thiers, George J. Hruza, Lindy P. Fox |
281 |
[GO] |
2020―Jun―27 |
Time to revisit HIPAA? Accelerated telehealth adoption during the COVID-19 pandemic |
Bhate, Chinmoy, Chin Hung Ho, Robert T. Brodell |
282 |
[GO] |
2020―Jun―27 |
Experience in patients with hidradenitis suppurativa and COVID-19 symptoms |
José Luis Galán Sánchez, Catiana Silvente San Nicasio, Mónica González Olivares, Claudia García Martín, Kevin Díez Madueño, María Ángeles Martín Díaz, Diana Velázquez Tarjuelo, Pablo de la Cueva Dobao |
283 |
[GO] |
2020―Jun―27 |
Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery |
Mytrang H. Do, Kira Minkis, Tatyana A. Petukhova, Shari R. Lipner |
284 |
[GO] |
2020―Jun―24 |
Dear Dermatoethicist: Medical Student Dermatology Rotations in the Context of COVID-19 |
Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng |
285 |
[GO] |
2020―Jun―22 |
Comment on: “To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients.” |
D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, P. Burgos-Blasco, J. Jimenez-Cauhe, M. Fernandez-Guarino |
286 |
[GO] |
2020―Jun―19 |
When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection |
William Damsky, Danielle Peterson, Brett King |
287 |
[GO] |
2020―Jun―19 |
Navigating Immunosuppression in a Pandemic: A Guide for the Dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists |
Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy P. Fox, Joanna Harp, Robert G. Micheletti, Vinod E. Nambudiri, Helena B. Pasieka, Michi M. Shinohara, Misha Rosenbach, Joseph F. Merola |
288 |
[GO] |
2020―Jun―17 |
Dear Dermatoethicist:The Ethics of Charging Patients an Infection Control Fee in the Context of COVID-19 |
Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng |
289 |
[GO] |
2020―Jun―17 |
International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries |
Esther E. Freeman, Devon E. McMahon, George J. Hruza, Alan D. Irvine, Phyllis I. Spuls, Catherine H. Smith, Satveer K. Mahil, Leslie Castelo-Soccio, Kelly M. Cordoro, Irene Lara-Corrales, Haley B. Naik, Raed Alhusayen, John R. Ingram, Steven R. Feldman, Esther A. Balogh, Michael D. Kappelman, Dmitri Wall, Nekma Meah, Rodney Sinclair, Marie Beylot-Barry, Matthew Fitzgerald, Lars E. French, Henry W. Lim, Christopher E.M. Griffiths, Carsten Flohr |
290 |
[GO] |
2020―Jun―15 |
Third year Dermatology Resident Anxiety in the Era of COVID-19 |
Nagasai C. Adusumilli, Misty Eleryan, Shelly Tanner, Adam J. Friedman |
291 |
[GO] |
2020―Jun―15 |
Fighting COVID-19: Early Teledermatology Lessons Learned |
Jean S. McGee, Rachel V. Reynolds, Suzanne M. Olbricht |
292 |
[GO] |
2020―Jun―15 |
Redeployment of Dermatologists During COVID-19: Implementation of a Large-Scale, Centralized Results Management Infrastructure |
Nina A. Ran, Sara S. Samimi, Junqian Zhang, Krisda H. Chaiyachati, Colleen P. Mallozzi, C. William Hanson, John T. Howell, Susan C. Day, Nicholas K. Mollanazar |
293 |
[GO] |
2020―Jun―14 |
Asynchronous teledermatology in medical education: Lessons from the COVID-19 pandemic |
Mack Y. Su, Evelyn Lilly, JiaDe Yu, Shinjita Das |
294 |
[GO] |
2020―Jun―10 |
Analysis of availability, types, and implementation of teledermatology services during COVID-19 |
Pavane L. Gorrepati, Gideon P. Smith |
295 |
[GO] |
2020―Jun―10 |
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic |
Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu |
296 |
[GO] |
2020―Jun―10 |
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic |
Cristiana Colonna, Giovanni Genovese, Nicola Adriano Monzani, Marina Picca, Francesca Boggio, Raffaele Gianotti, Angelo Valerio Marzano |
297 |
[GO] |
2020―Jun―06 |
The presence and distribution of novel coronavirus in medical environment |
Qianli Jiang, Yinghua Chen, Yingchun Dai, Guodong Hu |
298 |
[GO] |
2020―Jun―04 |
Analysis of dermatology-related search engine trends during the COVID-19 pandemic: implications for patient demand for outpatient services and telehealth. |
Anthony K. Guzman, John S. Barbieri |
299 |
[GO] |
2020―Jun―04 |
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19? |
Aurora Parodi, Giulia Gasparini, Emanuele Cozzani |
300 |
[GO] |
2020―Jun―03 |
Considerations for Underrepresented in Medicine Dermatology Residency Applicants Amidst the COVID-19 Pandemic |
Virginia A. Jones, Kayla A. Clark, Payal M. Patel, Adriana Cordova, Maria M. Tsoukas |
301 |
[GO] |
2020―Jun―02 |
Comment on: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak” |
D. Fernandez-Nieto, J. Jimenez-Cauhe, A. Suarez-Valle, O.M. Moreno-Arrones, D. Saceda-Corralo, A. Arana-Raja, D. Ortega-Quijano |
302 |
[GO] |
2020―Jun―02 |
CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC (“COVID TOES”): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES |
Jean Kanitakis, Cécile Lesort, Marie Danset, Denis Jullien |
303 |
[GO] |
2020―Jun―01 |
A Potential Hidden Reservoir: The Role of Nail Hygiene in Preventing Transmission of COVID-19 |
Albert G. Wu, Shari R. Lipner |
304 |
[GO] |
2020―Jun―01 |
Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak” |
Giuseppe Ruggiero, Fabio Arcangeli, Torello Lotti, Orsola Ametrano, Cosimo Ruggiero, Salvatore Cucchiara, Salvatore Oliva |
305 |
[GO] |
2020―Jun―01 |
Modifications to Dermatology Residency Education During the COVID-19 Pandemic. |
Asfandyar Mufti, Khalad Maliyar, Muskaan Sachdeva, Phillip Doiron |
306 |
[GO] |
2020―Jun―01 |
Dermatopathology Education During the COVID-19 Pandemic: Virtual Simulation of the Multi-Headed Microscope |
Randie H. Kim, Nooshin K. Brinster, Shane A. Meehan |
307 |
[GO] |
2020―Jun―01 |
Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: implications for the dermatology department |
Yamin Zhang, Jingjing Wen, Cai Chen, Lingling Zeng, Liu Yang, Changzheng Huang, Aiping Feng, Xiaoping Miao, Mahin Alamgir, Babar Rao, Yan Li, Juan Tao |
308 |
[GO] |
2020―May―30 |
Advances in skin science enable the development of a COVID-19 Vaccine |
Louis D. Falo |
309 |
[GO] |
2020―May―30 |
Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries |
Esther E. Freeman, Devon E. McMahon, Jules B. Lipoff, Misha Rosenbach, Carrie Kovarik, Junko Takeshita, Lars E. French, Bruce H. Thiers, George J. Hruza, Lindy P. Fox |
310 |
[GO] |
2020―May―22 |
Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions |
Vincenzo Piccolo, Andrea Bassi |
311 |
[GO] |
2020―May―22 |
Recommendations for Medical Student Preparedness and Equity for Dermatology Residency Applications During the COVID-19 Pandemic |
Claire R. Stewart, Karen A. Chernoff, Horatio F. Wildman, Shari R. Lipner |
312 |
[GO] |
2020―May―22 |
Reply to Notes and Comments on “Proposed Approach 1 for Re-using Surgical Masks in COVID-19 Pandemic” |
Yuangang Liu, Sancy A. Leachman, Anna Bar |
313 |
[GO] |
2020―May―22 |
Prescription Restrictions on Hydroxychloroquine Among the Largest Florida Pharmacy Chains During the COVID-19 Pandemic: An Observational Study |
Edward Hadeler, Fleta Bray |
314 |
[GO] |
2020―May―22 |
Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the “Gabrin sign” |
Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, Alba Gomez-Zubiaur, Sabina Herrera, Ángela Hermosa-Gelbard, Oscar M. Moreno-Arrones, Natalia Jiménez-Gómez, Alvaro González-Cantero, Pablo Fonda Pascual, Gonzalo Segurado-Miravalles, Jerry Shapiro, Bibiana Pérez-García, Andy Goren |
315 |
[GO] |
2020―May―21 |
Comment on: “Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions” |
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, Ortega-Quijano D |
316 |
[GO] |
2020―May―21 |
Notes and Comments on “Proposed Approach for Re-using Surgical Masks in COVID-19 Pandemic” |
Angeli Eloise Torres, David M. Ozog, Iltefat H. Hamzavi, Henry W. Lim |
317 |
[GO] |
2020―May―20 |
Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients”: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. |
Mar Llamas-Velasco, Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, E. Daudén |
318 |
[GO] |
2020―May―19 |
Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy |
Vincenzo De Giorgi, Sebastiano Recalcati, Ziyi Jia, Wei Chong, Renyu Ding, Yunhua Deng, Federica Scarfi, Federico Venturi, Luciana Trane, Alessia Gori, Flavia Silvestri, Xing-Hua Gao, Torello Lotti |
319 |
[GO] |
2020―May―19 |
The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic |
Marilyn T. Wan, Daniel B. Shin, Kevin L. Winthrop, Joel M. Gelfand |
320 |
[GO] |
2020―May―19 |
Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment |
Muskaan Sachdeva, Asfandyar Mufti, Khalad Maliyar, Yuliya Lytvyn, Jensen Yeung |
321 |
[GO] |
2020―May―19 |
Response to “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients’: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out” |
Angelo Valerio Marzano, Giovanni Genovese |
322 |
[GO] |
2020―May―17 |
Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections |
Yu Wang, Shari R. Lipner |
323 |
[GO] |
2020―May―16 |
The Immediate Impact of COVID-19 on US Dermatology Practices |
Graham H. Litchman, Darrell S. Rigel |
324 |
[GO] |
2020―May―16 |
Head and neck surgery is a high-risk procedure for COVID-19 transmission and there is a need for a preventive strategy to protect professionals |
Ignacio Garcia-Doval |
325 |
[GO] |
2020―May―16 |
Cutaneous Manifestations of COVID-19: A Preliminary Review |
Justin L. Jia, Marija Kamceva, Saieesh A. Rao, Eleni Linos |
326 |
[GO] |
2020―May―15 |
COVID-19 & PPE: Treatment and Prevention of Skin Conditions Related to the Occupational Use of Personal Protective Equipment |
Seemal R. Desai, Carrie Kovarik, Bruce Brod, William James, Matthew E. Fitzgerald, Ave Preston, George J. Hruza |
327 |
[GO] |
2020―May―14 |
Algorithm for the classification of Covid-19 rashes |
Daniel Ortega-Quijano, Juan Jimenez-Cauhe, Gerald Selda-Enriquez, Montserrat Fernandez-Guarino, Diego Fernandez-Nieto |
328 |
[GO] |
2020―May―14 |
Reply to: Skin damage among healthcare workers managing coronavirus disease-2019 |
Khalad Maliyar, Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung |
329 |
[GO] |
2020―May―13 |
Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic |
Monica Shah, Muskaan Sachdeva, Afsaneh Alavi, Vivian Y. Shi, Jennifer L. Hsiao |
330 |
[GO] |
2020―May―13 |
Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective |
Shari R. Lipner, Matilde Iorizzo, Nathaniel Jellinek, Bianca Maria Piraccini, Richard K. Scher |
331 |
[GO] |
2020―May―12 |
Dear Dermatoethicist: Web-Based Dermatology Residency Interviews in the Time of COVID-19 |
Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng |
332 |
[GO] |
2020―May―12 |
COVID-19 and its impact on medical student education in dermatology |
Tiffany Y. Loh, Jennifer L. Hsiao, Vivian Y. Shi |
333 |
[GO] |
2020―May―11 |
Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey |
Yehong Kuang, Minxue Shen, Qiaolin Wang, Yi Xiao, Chengzhi Lv, Yan Luo, Wu Zhu, Xiang Chen |
334 |
[GO] |
2020―May―08 |
Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients |
Janyla A. Seltzer, Chidubem A.V. Okeke, Jessica D. Perry, William D. Shipman, Ginette A. Okoye, Angel S. Byrd |
335 |
[GO] |
2020―May―07 |
Reply: A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis |
Iviensan F. Manalo, Molly K. Smith, Justin Cheeley, Randy Jacobs |
336 |
[GO] |
2020―May―07 |
Reply to: “A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis” |
Cristina Thomas |
337 |
[GO] |
2020―May―06 |
COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy |
Andrea Carugno, Daniele Mario Gambini, Francesca Raponi, Pamela Vezzoli, Andrea Gustavo C. Locatelli, Marco Di Mercurio, Elisa Robustelli Test, Paolo Sena |
338 |
[GO] |
2020―May―06 |
Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic |
Larisa J. Geskin, Megan H. Trager, Sumaira Z. Aasi, David R. Bickers, Richard D. Carvajal, Paul Nghiem, Bret Taback, Nathalie C. Zeitouni, Faramarz H. Samie |
339 |
[GO] |
2020―May―04 |
The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations |
Sepideh Ashrafzadeh, Vinod E. Nambudiri |
340 |
[GO] |
2020―May―04 |
Invited Commentary on the letter "The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations." |
Carrie Kovarik, Ivy Lee, Trilokraj Tejasvi, Jules B. Lipoff |
341 |
[GO] |
2020―May―04 |
Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic |
Daniela P. Sanchez, Robert S. Kirsner, Hadar Lev-Tov |
342 |
[GO] |
2020―May―04 |
Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern. |
Lidia Rudnicka, Mohamad Goldust, Paulina Glowacka, Mariusz Sikora, Marta Sar-Pomian, Adriana Rakowska, Zbigniew Samochocki, Malgorzata Olszewska |
343 |
[GO] |
2020―May―04 |
Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France |
Adèle de Masson, Jean-David Bouaziz, Luc Sulimovic, Charles Cassius, Marie Jachiet, Marius-Anton Ionescu, Michel Rybojad, Martine Bagot, Tu-Anh Duong |
344 |
[GO] |
2020―May―04 |
Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients”: discussing specificity |
Daniel Ortega-Quijano, Juan Jimenez-Cauhe, Patricia Burgos-Blasco, Natalia Jimenez-Gomez, Diego Fernandez-Nieto |
345 |
[GO] |
2020―May―01 |
Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic |
Monica Shah, Haley B. Naik, Raed Alhusayen |
346 |
[GO] |
2020―May―01 |
COVID-19:Should sexual practices be discouraged during the pandemic? |
ZhiQiang Yin |
347 |
[GO] |
2020―May―01 |
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatological and rheumatological patients already under treatment. |
Maria Vastarella, Angela Patrì, Maria Carmela Annunziata, Mariateresa Cantelli, Paola Nappa, Marco Tasso, Luisa Costa, Francesco Caso, Gabriella Fabbrocini |
348 |
[GO] |
2020―Apr―27 |
Calm before the storm: understanding the role of JAK inhibitors in COVID-19 |
Danielle Peterson, William Damsky, Brett King |
349 |
[GO] |
2020―Apr―27 |
Proposed approach for reusing surgical masks in COVID-19 pandemic |
Yuangang Liu, Sancy Leachman, Anna Bar |
350 |
[GO] |
2020―Apr―27 |
What matters most: Why the COVID-19 pandemic should prompt us to revisit the dermatology resident selection process |
Daniel Karasik, Daniel M. O’Connor, Neera R. Nathan |
351 |
[GO] |
2020―Apr―27 |
Risks of Hydroxychloroquine use for COVID-19 prophylaxis |
Muskaan Sachdeva, Monica Shah, Michael Ziv, Eyal Leshem, Roni P. Dodiuk-Gad |
352 |
[GO] |
2020―Apr―27 |
Response to “Risks of Hydroxychloroquine use for COVID-19 prophylaxis” |
Jane M. Grant-Kels |
353 |
[GO] |
2020―Apr―27 |
Reply to: Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission |
Gregory Cavanagh, Carlos Wambier |
354 |
[GO] |
2020―Apr―24 |
Potential role of Janus kinase inhibitors in COVID-19 |
Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno |
355 |
[GO] |
2020―Apr―24 |
Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak |
D. Fernandez-Nieto, J. Jimenez-Cauhe, A. Suarez-Valle, O.M. Moreno-Arrones, D. Saceda-Corralo, A. Arana-Raja, D. Ortega-Quijano |
356 |
[GO] |
2020―Apr―24 |
Recommendations for phototherapy during the COVID-19 pandemic |
Henry W. Lim, Steven R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand |
357 |
[GO] |
2020―Apr―24 |
Telemedicine for Inpatient Dermatology Consultations in Response to the COVID-19 Pandemic |
John Trinidad, Daniela Kroshinksy, Benjamin H. Kaffenberger, Nathan Rojek |
358 |
[GO] |
2020―Apr―24 |
Cutaneous manifestations in COVID-19: Lessons learned from current evidence |
Poonkiat Suchonwanit, Kanchana Leerunyakul, Chaninan Kositkuljorn |
359 |
[GO] |
2020―Apr―22 |
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment |
Paolo Gisondi, Gianluigi Zaza, Micol Del Giglio, Mattia Rossi, Valentina Iacono, Giampiero Girolomoni |
360 |
[GO] |
2020―Apr―22 |
Teledermatology in the Wake of COVID-19: Advantages and Challenges to Continued Care in a Time of Disarray |
Rohit Gupta, Marina K. Ibraheim, Hung Q. Doan |
361 |
[GO] |
2020―Apr―21 |
Invited response to the comment on “Dermatology Residents and the Care of COVID-19 Patients” |
Jane M. Grant-Kels |
362 |
[GO] |
2020―Apr―21 |
Comment on “Dermatology Residents and the Care of COVID-19 Patients” |
Basil Patel |
363 |
[GO] |
2020―Apr―21 |
Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission |
Mohit Kumar Gupta, Shari R. Lipner |
364 |
[GO] |
2020―Apr―17 |
The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |
Esther E. Freeman, Devon E. McMahon, Matthew E. Fitzgerald, Lindy P. Fox, Misha Rosenbach, Junko Takeshita, Lars E. French, Bruce H. Thiers, George J. Hruza |
365 |
[GO] |
2020―Apr―17 |
COVID-19 and Racial Disparities |
Monica Shah, Muskaan Sachdeva, Roni P. Dodiuk-Gad |
366 |
[GO] |
2020―Apr―17 |
Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology |
Sara Perkins, Jeffrey M. Cohen, Caroline A. Nelson, Christopher G. Bunick |
367 |
[GO] |
2020―Apr―16 |
Letter from the Editors: Big Data and Cutaneous Manifestations of COVID-19 |
Jane M. Grant-Kels, Brett Sloan, Jonathan Kantor, Dirk M. Elston |
368 |
[GO] |
2020―Apr―16 |
United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic |
J.A. Zic, W. Ai, O.E. Akilov, J.B. Carter, M. Duvic, F. Foss, M. Girardi, A.A. Gru, E. Kim, A. Musiek, E.A. Olsen, S.M. Schieke, M. Shinohara, J.M. Zain, L.J. Geskin |
369 |
[GO] |
2020―Apr―16 |
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients |
Angelo Valerio Marzano, Giovanni Genovese, Gabriella Fabbrocini, Paolo Pigatto, Giuseppe Monfrecola, Bianca Maria Piraccini, Stefano Veraldi, Pietro Rubegni, Marco Cusini, Valentina Caputo, Franco Rongioletti, Emilio Berti, Piergiacomo Calzavara-Pinton |
370 |
[GO] |
2020―Apr―16 |
Overzealous hand hygiene during COVID 19 pandemic causing increased incidence of hand eczema among general population |
Mehak Singh, Manoj Pawar, Atul Bothra, Nishant Choudhary |
371 |
[GO] |
2020―Apr―10 |
Back to the Basics: Diluted Bleach for COVID-19 |
Parth Patel, Sanjna Sanghvi, Kunal Malik, Amor Khachemoune |
372 |
[GO] |
2020―Apr―10 |
Various forms of skin rash in COVID-19 : a reply |
Beuy Joob, Viroj Wiwanitkit |
373 |
[GO] |
2020―Apr―10 |
Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? |
Angela Patrì, Gabriella Fabbrocini |
374 |
[GO] |
2020―Apr―10 |
Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: Petechial rash in a patient with COVID-19 infection |
Juan Jimenez-Cauhe, Daniel Ortega-Quijano, Marta Prieto-Barrios, Oscar M. Moreno-Arrones, Diego Fernandez-Nieto |
375 |
[GO] |
2020―Apr―10 |
Biologics for psoriasis during COVID-19 outbreak |
Vito Di Lernia |
376 |
[GO] |
2020―Apr―10 |
Reply to: “Biologics for psoriasis during COVID-19 outbreak” |
Dedee F. Murrell, Ryan Rivera-Oyola, Mark Lebwohl |
377 |
[GO] |
2020―Apr―10 |
Recommendations on dermatologic surgery during the COVID-19 pandemic |
Samuel Antranig Der Sarkissian, Leo Kim, Michael Veness, Eleni Yiasemides, Deshan Frank Sebaratnam |
378 |
[GO] |
2020―Apr―10 |
Optimizing Teledermatology Visits for Dermatology Resident Education During the COVID-19 Pandemic |
Reid Oldenburg, Amanda Marsch |
379 |
[GO] |
2020―Apr―10 |
Treatment considerations for patients with pemphigus during the COVID-19 pandemic |
Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F. Murrell, Julia S. Lehman |
380 |
[GO] |
2020―Apr―10 |
Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations |
Alecia Blaszczak, John C.L. Trinidad, Alexander M. Cartron |
381 |
[GO] |
2020―Apr―10 |
Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease |
Esther E. Freeman, Devon E. McMahon |
382 |
[GO] |
2020―Apr―10 |
A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis |
Iviensan F. Manalo, Molly K. Smith, Justin Cheeley, Randy Jacobs |
383 |
[GO] |
2020―Apr―10 |
Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence |
Erisa Alia, Jane M. Grant-Kels |
384 |
[GO] |
2020―Apr―10 |
Reply to: “Skin damage among healthcare workers managing coronavirus disease-2019” |
Teresa Oranges, Agata Janowska, Valentina Dini |
385 |
[GO] |
2020―Apr―10 |
SARS-COV-2 infection is likely to be androgen mediated |
Carlos Gustavo Wambier, Andy Goren |
386 |
[GO] |
2020―Apr―10 |
Sexual transmission of SARS-CoV-2: a new possible route of infection? |
Angela Patrì, Lucia Gallo, Maria Guarino, Gabriella Fabbrocini |
387 |
[GO] |
2020―Apr―09 |
The use of Janus kinase inhibitors in the time of SARS-CoV-2 |
Danielle Peterson, William Damsky, Brett King |
388 |
[GO] |
2020―Apr―08 |
Strategic Dermatology Clinical Operations During COVID-19 Pandemic |
Kyla N. Price, Rebecca Thiede, Vivian Y. Shi, Clara Curiel-Lewandrowski |
389 |
[GO] |
2020―Apr―05 |
Rational hand hygiene during COVID-19 pandemic |
Gregory Cavanagh, Carlos Wambier |
390 |
[GO] |
2020―Apr―04 |
Dermatology Residents and the Care of COVID-19 Patients |
Victoria J. Stoj, Jane M. Grant-Kels |
391 |
[GO] |
2020―Apr―01 |
Ultraviolet germicidal irradiation: possible method for respirator disinfection to facilitate reuse during COVID-19 pandemic |
Iltefat H. Hamzavi, Alexis B. Lyons, Indermeet Kohli, Shanthi Narla, Angela Parks-Miller, Joel M. Gelfand, Henry W. Lim, David Ozog |
392 |
[GO] |
2020―Apr―01 |
COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution |
Naveen Kumar Kansal |
393 |
[GO] |
2020―Mar―31 |
Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic |
Payal Shah, John G. Zampella |
394 |
[GO] |
2020―Mar―31 |
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment |
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi |
395 |
[GO] |
2020―Mar―28 |
Telehealth: Helping Your Patients and Practice Survive and Thrive During the COVID-19 Crisis with Rapid Quality Implementation |
Ivy Lee, Carrie Kovarik, Trilokraj Tejasvi, Michelle Pizarro, Jules B. Lipoff |
396 |
[GO] |
2020―Mar―26 |
COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology |
Kyla N. Price, John W. Frew, Jennifer L. Hsiao, Vivian Y. Shi |
397 |
[GO] |
2020―Mar―26 |
Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic |
James T. Pathoulas, Benjamin K. Stoff, Kachiu C. Lee, Ronda S. Farah |
398 |
[GO] |
2020―Mar―22 |
COVID-19 can present with a rash and be mistaken for Dengue |
Beuy joob, Viroj Wiwanitkit |
399 |
[GO] |
2020―Mar―22 |
Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatolgy visits |
Shawn G. Kwatra, Ronald J. Sweren, Anna L. Grossberg |
400 |
[GO] |
2020―Mar―19 |
Should biologics for psoriasis be interrupted in the era of COVID-19? |
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F. Murrell |
401 |
[GO] |
2020―Mar―18 |
Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID-19) epidemic |
Dirk M. Elston |
402 |
[GO] |
2020―Mar―18 |
Behavioral considerations and impact on personal protective equipment (PPE) use: Early lessons from the coronavirus (COVID-19) outbreak |
Jonathan Kantor |
403 |
[GO] |
2020―Mar―18 |
Skin damage among healthcare workers managing coronavirus disease-2019 |
Jiajia Lan, Zexing Song, Xiaoping Miao, Hang Li, Yan Li, Liyun Dong, Jing Yang, Xiangjie An, Yamin Zhang, Liu Yang, Nuoya Zhou, Liu Yang, Jun Li, JingJiang Cao, Jianxiu Wang, Juan Tao |
404 |
[GO] |
2020―Feb―17 |
What are we doing in the dermatology outpatient department amidst the raging of 2019-nCoV? |
Yusha Chen, Sushmita Pradhan, Siliang Xue |